Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19

Publication date: August 2021Source: Pulmonary Pharmacology & Therapeutics, Volume 69Author(s): Marie Fisk, Magnus Althage, Sven Moosmang, Peter J. Greasley, Andrew P. Cope, David RW. Jayne, James Galloway, Frances Hall, Ian B. Wilkinson, Philip Ambery, Joseph Cheriyan
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research